PURE Bioscience (OTCMKTS:PURE) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

PURE Bioscience (OTCMKTS:PURE)’s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.0699. PURE Bioscience shares last traded at $0.0684, with a volume of 5,927 shares.

PURE Bioscience Stock Performance

The business’s 50 day moving average is $0.07 and its 200 day moving average is $0.06. The stock has a market cap of $7.65 million, a price-to-earnings ratio of -2.28 and a beta of 0.26.

PURE Bioscience (OTCMKTS:PURE) last posted its quarterly earnings data on Monday, March 16th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.44 million for the quarter.

About PURE Bioscience

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.